Results 131 to 140 of about 40,848 (156)

Therapeutic potential of S-nitrosoglutathione reductase inhibitor in B cell-driven experimental autoimmune encephalomyelitis. [PDF]

J Neuroimmunol
Won J, Kim J, Qiao F, Singh AK, Singh I.
europepmc   +1 more source

Targeted lipidomics dataset of central nervous system and plasma from mice with experimental autoimmune encephalomyelitis. [PDF]

Data Brief
Lötsch J, Tegder I, de Bruin N, Thomas D, Geisslinger G.   +4 more
europepmc   +1 more source

Mechanistic insights from experimental autoimmune encephalomyelitis into immune regulation, autophagy, gut microbiota, blood-brain barrier integrity, and NLRP3 inflammasome-mediated pyroptosis in multiple sclerosis: potential clinical implications. [PDF]

Front Neurosci
Zhang SM, Tang WC, Liu FF, Bai QQ, Guo Y, Bai XZ, Wang YF, Ma XY, Pan SJ, Yang YH, Du GQ, Fan H.   +11 more
europepmc   +1 more source

Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis. [PDF]

Clin Transl Immunology
Denny L, Robichon K, Templeton N, Kiernan M, Prisinzano TE, Kivell BM, La Flamme AC.   +6 more
europepmc   +1 more source

Attenuating the experimental autoimmune encephalomyelitis model improves preclinical evaluation of candidate multiple sclerosis therapeutics. [PDF]

Animal Model Exp Med
Lim VJT, Murphy MJ, Penrose WS, Warr C, Keightley MC, Orian JM.   +5 more
europepmc   +1 more source

Differences of the 6N and 6J Substrains of C57BL/6 Mice in the Development of Experimental Autoimmune Encephalomyelitis. [PDF]

MedComm (2020)
Álvarez-López AI, Ponce-España E, Cruz-Chamorro I, Santos-Sánchez G, Bejarano I, Álvarez-Sánchez N, Lardone PJ, Carrillo-Vico A.   +7 more
europepmc   +1 more source

Astrocytic-OTUD7B ameliorates murine experimental autoimmune encephalomyelitis by stabilizing glial fibrillary acidic protein and preventing inflammation. [PDF]

Nat Commun
Harit K, Yi W, Jeron A, Schmidt J, Beckervordersandforth R, Wyler E, Manukyan A, Deckert M, Radbruch H, Conrad T, Altmüller J, Landthaler M, Wang X, Nishanth G, Schlüter D.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8)

Cells, 2022
, Paul M Epstein, Stefan Brocke
exaly  

Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis

Clinical and Experimental Immunology, 2022
Shen Donghui
exaly  

<p>Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis</p>

Journal of Inflammation Research, 2020
Azzam Maghazachi, Noha Mousaad Elemam
exaly